跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PMS-NILOTINIB
Authorized
STANDARD
PMS-NILOTINIB
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Mar 30, 2026
Approval ID
72ee74671d35e66f
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
72ee74671d35e66f
Drug Approval Canada Name
PMS-NILOTINIB
Product Name
PMS-NILOTINIB
Status
Approved
Status Date
2026-02-02
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
10:00.00
Atc Original
L01EA03 NILOTINIB
Aig Number
0152484002
Company Name
Pharmascience Inc
Company Address
100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Mar 30, 2026
Approval ID
72ee74671d35e66f
Type
Standard
Back to Health Canada Approvals
PMS-NILOTINIB - Health Canada Drug Approval Details